BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29139358)

  • 1. Management of Cutaneous Cancers in Patients Undergoing Organ Transplantation-Part I: Current Status: Reactive Approach.
    Sharma D; Handler MZ; Shah R; Weiss A; Lambert MW; Gagna CE; Lambert WC
    Skinmed; 2017; 15(5):329-331. PubMed ID: 29139358
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin cancers after organ transplantation.
    Euvrard S; Kanitakis J; Claudy A
    N Engl J Med; 2003 Apr; 348(17):1681-91. PubMed ID: 12711744
    [No Abstract]   [Full Text] [Related]  

  • 3. Iatrogenic immunosuppression and cutaneous malignancy.
    DePry JL; Reed KB; Cook-Norris RH; Brewer JD
    Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
    Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
    Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell and squamous cell skin cancers.
    Miller SJ; Alam M; Andersen J; Berg D; Bichakjian CK; Bowen G; Cheney RT; Glass F; Grekin RC; Grichnik JM; Kessinger A; Lee NY; Lessin S; Lydiatt DD; Margolis LW; Michalski J; Nehal KS; Nghiem P; Oseroff AR; Rosenberg EW; Shaha AR; Siegle RJ; Urist MM;
    J Natl Compr Canc Netw; 2007 May; 5(5):506-29. PubMed ID: 17509254
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin diseases following organ transplantation--risk factors and new therapeutic approaches.
    Stockfleth E; Ulrich C; Meyer T; Arndt R; Christophers E
    Transplant Proc; 2001; 33(1-2):1848-53. PubMed ID: 11267539
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
    Herman S; Rogers HD; Ratner D
    Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk cutaneous malignancies and immunosuppression: Challenges for the reconstructive surgeon in the renal transplant population.
    Kearney L; Hogan D; Conlon P; Roche M; O'Neill JP; O'Sullivan JB
    J Plast Reconstr Aesthet Surg; 2017 Jul; 70(7):922-930. PubMed ID: 28457679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmelanoma skin cancer in organ transplant recipients: increase without delay after transplant and subsequent acceleration.
    Muehleisen B; Pazhenkottil A; French LE; Hofbauer GF
    JAMA Dermatol; 2013 May; 149(5):618-20. PubMed ID: 23677099
    [No Abstract]   [Full Text] [Related]  

  • 10. Basal cell and squamous cell skin cancers.
    Miller SJ; Alam M; Andersen J; Berg D; Bichakjian CK; Bowen G; Cheney RT; Glass LF; Grekin RC; Kessinger A; Lee NY; Liegeois N; Lydiatt DD; Michalski J; Morrison WH; Nehal KS; Nelson KC; Nghiem P; Olencki T; Perlis CS; Rosenberg EW; Shaha AR; Urist MM; Wang LC; Zic JA
    J Natl Compr Canc Netw; 2010 Aug; 8(8):836-64. PubMed ID: 20870631
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of skin cancer after organ transplantation.
    Lumbang W; Stasko T
    G Ital Dermatol Venereol; 2011 Oct; 146(5):341-52. PubMed ID: 21956271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In this issue: Reverse translation.
    Rees J; Naysmith L
    Acta Derm Venereol; 2010 Sep; 90(5):450-3. PubMed ID: 20814615
    [No Abstract]   [Full Text] [Related]  

  • 13. NMSC in organ transplant recipients and other high-risk groups.
    Pennington BE; Stasko T
    J Natl Compr Canc Netw; 2004 Jan; 2(1):31-41. PubMed ID: 19777693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocyte cancer and its precursors in organ transplant patients.
    Jenni D; Hofbauer GF
    Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous cancers after organ transplantation].
    Quatresooz P; Piérard GE; Paquet P; Blaise G; Piérard-Franchimont C
    Rev Med Liege; 2007 Nov; 62(11):663-8. PubMed ID: 18217642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the transplant physician in the management of skin cancers after organ transplantation.
    Morelon E; Mahe E; Touraine JL
    Cancer Treat Res; 2009; 146():377-90. PubMed ID: 19415217
    [No Abstract]   [Full Text] [Related]  

  • 18. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
    Randle HW
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer after transplantation: where did we come from, where do we go?
    Marks R
    Cancer Treat Res; 2009; 146():5-7. PubMed ID: 19415189
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplant-associated skin cancer: role of reducing immunosuppression.
    Neuburg M
    J Natl Compr Canc Netw; 2007 May; 5(5):541-9. PubMed ID: 17509256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.